Literature DB >> 16796369

Dissolution improvement of high drug-loaded solid dispersion.

Siriporn Okonogi1, Satit Puttipipatkhachorn.   

Abstract

This study focused on an investigation of a high drug-loaded solid dispersion system consisting of drug, carrier, and surfactant. Solid dispersions of a water-insoluble ofloxacin (OFX) with polyethylene glycol (PEG) of different molecular weights, namely binary solid dispersion systems, were prepared at drug to carrier not less than 5:5. Polysorbate 80, a nonionic surfactant, was incorporated into the binary solid dispersion systems as the third component to obtain the ternary solid dispersion systems. The powder x-ray diffraction and differential scanning calorimetric studies indicated that crystalline OFX existed in the solid dispersions with high drug loading. However, a decreased crystallinity of the solid dispersions obtained revealed that a portion of OFX was in an amorphous state. The results indicated a remarkably improved dissolution of drug from the ternary solid dispersion systems when compared with the binary solid dispersion systems. This was because of polysorbate 80, which improved wettability and solubilized the non-molecularly dispersed or crystalline fraction of OFX.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16796369      PMCID: PMC2750279          DOI: 10.1208/pt070252

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  11 in total

1.  Thermal behavior of ursodeoxycholic acid in urea: identification of anomalous peak in the thermal analysis.

Authors:  S Okonogi; S Puttipipatkhachorn; K Yamamoto
Journal:  Drug Dev Ind Pharm       Date:  2001-09       Impact factor: 3.225

Review 2.  The mechanisms of drug release from solid dispersions in water-soluble polymers.

Authors:  Duncan Q M Craig
Journal:  Int J Pharm       Date:  2002-01-14       Impact factor: 5.875

Review 3.  Pharmaceutical applications of solid dispersion systems.

Authors:  W L Chiou; S Riegelman
Journal:  J Pharm Sci       Date:  1971-09       Impact factor: 3.534

4.  Solid dispersion of ketoprofen in pellets.

Authors:  R Jachowicz; E Nürnberg; B Pieszczek; B Kluczykowska; A Maciejewska
Journal:  Int J Pharm       Date:  2000-09-25       Impact factor: 5.875

5.  Drug physical state and drug-polymer interaction on drug release from chitosan matrix films.

Authors:  S Puttipipatkhachorn; J Nunthanid; K Yamamoto; G E Peck
Journal:  J Control Release       Date:  2001-07-10       Impact factor: 9.776

6.  Influence of water-soluble polymers on the dissolution of nifedipine solid dispersions with combined carriers.

Authors:  H Suzuki; H Sunada
Journal:  Chem Pharm Bull (Tokyo)       Date:  1998-03       Impact factor: 1.645

7.  Thermal behavior and dissolution properties of naproxen from binary and ternary solid dispersions.

Authors:  P Mura; M T Faucci; A Manderioli; G Bramanti; P Parrini
Journal:  Drug Dev Ind Pharm       Date:  1999-03       Impact factor: 3.225

8.  Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.

Authors:  S Sethia; E Squillante
Journal:  Int J Pharm       Date:  2004-03-19       Impact factor: 5.875

9.  Comparative dissolution studies for mefenamic acid-polyethylene glycol solid dispersion systems and tablets.

Authors:  G Owusu-Ababio; N K Ebube; R Reams; M Habib
Journal:  Pharm Dev Technol       Date:  1998-08       Impact factor: 3.133

10.  Structural properties of polyethylene glycol-polysorbate 80 mixture, a solid dispersion vehicle.

Authors:  K R Morris; G T Knipp; A T Serajuddin
Journal:  J Pharm Sci       Date:  1992-12       Impact factor: 3.534

View more
  9 in total

Review 1.  Challenges and opportunities in achieving bioequivalence for fixed-dose combination products.

Authors:  Amitava Mitra; Yunhui Wu
Journal:  AAPS J       Date:  2012-06-09       Impact factor: 4.009

2.  Characterization of cimetidine-piroxicam coprecipitate interaction using experimental studies and molecular dynamic simulations.

Authors:  Vimon Tantishaiyakul; Krit Suknuntha; Visit Vao-Soongnern
Journal:  AAPS PharmSciTech       Date:  2010-05-29       Impact factor: 3.246

3.  Microparticles Containing Curcumin Solid Dispersion: Stability, Bioavailability and Anti-Inflammatory Activity.

Authors:  C C C Teixeira; L M Mendonça; M M Bergamaschi; R H C Queiroz; G E P Souza; L M G Antunes; L A P Freitas
Journal:  AAPS PharmSciTech       Date:  2015-06-04       Impact factor: 3.246

4.  Evaluation of colloidal solid dispersions: physiochemical considerations and in vitro release profile.

Authors:  Vaibhav I Patel; Rutesh H Dave
Journal:  AAPS PharmSciTech       Date:  2013-03-15       Impact factor: 3.246

5.  Multifunctional chitosan-magnetic graphene quantum dot nanocomposites for the release of therapeutics from detachable and non-detachable biodegradable microneedle arrays.

Authors:  Richard Justin; Biqiong Chen
Journal:  Interface Focus       Date:  2018-04-20       Impact factor: 3.906

6.  Sustained release ivermectin-loaded solid lipid dispersion for subcutaneous delivery: in vitro and in vivo evaluation.

Authors:  Mengmeng Lu; Dan Xiong; Weiwei Sun; Tong Yu; Zixia Hu; Jiafeng Ding; Yunpeng Cai; Shizhuang Yang; Baoliang Pan
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

7.  Formulation development and dissolution rate enhancement of efavirenz by solid dispersion systems.

Authors:  P T Koh; J N Chuah; Meghna Talekar; A Gorajana; S Garg
Journal:  Indian J Pharm Sci       Date:  2013-05       Impact factor: 0.975

8.  Enhanced Bioavailability and Anticancer Effect of Curcumin-Loaded Electrospun Nanofiber: In Vitro and In Vivo Study.

Authors:  Chuan Wang; Chao Ma; Zhenkai Wu; He Liang; Peng Yan; Jia Song; Nan Ma; Qinghua Zhao
Journal:  Nanoscale Res Lett       Date:  2015-11-14       Impact factor: 4.703

9.  Oral Bioavailability Enhancement and Anti-Fatigue Assessment of the Andrographolide Loaded Solid Dispersion.

Authors:  Ching-Chi Yen; Yu-Kai Liang; Chao-Pei Cheng; Mei-Chich Hsu; Yu-Tse Wu
Journal:  Int J Mol Sci       Date:  2020-04-04       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.